[1] Padgett KA,Lan RY,Leung PC,et al. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun,2009,32:246-253.
[2] Qin B,Huang F,Liang Y,et al. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. J Gastroenterol Hepatol,2013,28:543-550.
[3] Liang DY,Hou YQ,Luo LJ,et al. Altered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosis. Int J Mol Med,2016,38:131-138.
[4] Lan RY,Cheng C,Lian ZX,et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology,2006,43:729-737.
[5] Takahashi R,Yoshimura A. SOCS1 and regulation of regulatory T cells plasticity. J Immunol Res,2014,2014:943149.
[6] Kempinska-Podhorodecka A,Milkiewicz M,Wasik U,et al. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway. Int J Mol Sci,2017,18:289.
[7] Qian C,Jiang T,Zhang W,et al. Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis. Cytokine,2013,64:172-180.
[8] Nakagawa R,Muroyama R,Saeki C,et al. miR-425 regulates inflammatory cytokine production in CD4(+) T cells via N-Ras upregulation in primary biliary cholangitis. J Hepatol,2017,66:1223-1230.
[9] Nakagawa R,Muroyama R,Saeki C,et al. CD4(+) T cells from patients with primary biliary cholangitis show T cell activation and differentially expressed T-cell receptor repertoires. Hepatol Res,2019,49:653-662.
[10] Song Y,Yang H,Jiang K,et al. miR-181a regulates Th17 cells distribution via up-regulated BCL-2 in primary biliary cholangitis. Int Immunopharmacol,2018,64:386-393.
[11] Zhang J,Zhang W,Leung PS,et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology,2014,60:1708-1716.
[12] Wang X,Wen X,Zhou J,et al. MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients. PLoS One,2017,12:e0184292.
[13] Sander S,Bullinger L,Klapproth K,et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood,2008,112:4202-4212.
[14] Sasaki M,Ikeda H,Sato Y,et al. Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am J Pathol,2006,169:831-845.
[15] Banales JM,Saez E,Uriz M,et al. Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology,2012,56:687-697.
[16] Erice O,Munoz-Garrido P,Vaquero J,et al. MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation. Hepatology,2018,67:1420-1440.
[17] Ananthanarayanan M,Banales JM,Guerra MT,et al. Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506. J Biol Chem,2015,290:184-196.
[18] Hirata K,Nathanson MH. Bile duct epithelia regulate biliary bicarbonate excretion in normal rat liver. Gastroenterology,2001,121:396-406.
[19] Minagawa N,Nagata J,Shibao K,et al. Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology,2007,133:1592-1602.
[20] Shibao K,Hirata K,Robert ME,et al. Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis. Gastroenterology,2003,125:1175-1187.
[21] Kim YC,Jung H,Seok S,et al. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice. Hepatology,2020,71:2118-2134.
[22] Afonso MB,Rodrigues PM,Simao AL,et al. miRNA-21 ablation protects against liver injury and necroptosis in cholestasis. Cell Death Differ,2018,25:857-872.
[23] Qian C,Chen SX,Ren CL,et al. Abnormal expression of miR-let-7b in primary biliary cirrhosis and its clinical significance. Zhonghua Gan Zang Bing Za Zhi,2013,21:533-536.
[24] Tan Y,Pan T,Ye Y,et al. Serum microRNAs as potential biomarkers of primary biliary cirrhosis. PLoS One,2014,9:e111424.
[25] Xiao C,Calado DP,Galler G,et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell,2007,131:146-159.
[26] Wasik U,Kempinska-Podhorodecka A,Bogdanos DP,et al. Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis. Mol Med,2020,26:8.
[27] Ninomiya M,Kondo Y,Funayama R,et al. Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. PLoS One,2013,8:e66086.
[28] Katsushima F,Takahashi A,Sakamoto N,et al. Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients. Hepatol Res,2014,44:E189-197.
[29] Sakamoto T,Morishita A,Nomura T,et al. Identification of microRNA profiles associated with refractory primary biliary cirrhosis. Mol Med Rep,2016,14:3350-3356. |
